Comorbid substance use disorders may complicate treatment for both the hepatologist and psychiatrist. Comprehensive assessment of psychiatric illness and psychopharmacological management may be critical.
Robert D. Canning, PhD
Advertisement
Articles by Robert D. Canning, PhD
Advertisement
Latest Updated Articles
- Depression as Co-Pilot: Clinical Implications of Hepatitis C and Interferon/Ribavirin Treatment
Published: April 1st 2005 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
Lithium-Loaded Gold Nanoparticle Nasal Spray to Treat Neuropsychiatric Diseases
2
The Trial of ChatGPT: What Psychiatrists Need to Know About AI, Suicide, and the Law
3
LSD for Generalized Anxiety Disorder: New Findings Review With Maurizio Fava, MD
4
Suicide: Can Emergency Departments Assist in its Prevention?
5
